xenon-pharma.com (XENE) - Uzoq muddatli majburiyatlarning kapitalga nisbati

xenon-pharma.com - XENE emitenti grafik logotipi

GURU.Markets platformasida Xenon Pharmaceuticals (XENE) qimmatli qog'ozlarining bozor dinamikasi epilepsiya davolash loyihalarining barqaror salohiyatini tasdiqlaydi, bunda ko'rsatkich 0.00 darajasida turibdi. Moliyaviy model kelajakdagi dori sotuvlariga tayanadi, bu esa sinovlar yakunlanmaguncha joriy daromadning tez-tez uchraydigan tebranishlari yuqori bo'lib qolishini anglatadi. Biroq, global keskinliklar dasturiy ta'minotni ishlab chiqishning yakuniy bosqichlari uchun zarur bo'lgan kapital kirimini cheklashi mumkin.

Xenon Pharmaceuticals Inc. (XENE): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

Xenon Pharmaceuticals (XENE) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Xenon Pharmaceuticals Inc.|XENE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Xenon|XENE - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Xenon Pharmaceuticals|XENE - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati xenon-pharma.com|XENE - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi xenon-pharma.com|XENE - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Xenon|XENE - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Xenon Pharmaceuticals|Shoshilinch likvidlik xenon-pharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
XENE - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:XENE (Xenon Pharmaceuticals Inc.)
Xenon Pharmaceuticals Inc. original mahsuloti

Ushbu koeffitsiyent uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, moliyaviy mustaqillik darajasini va biznesning qarz xarajatlariga chidamliligini belgilaydi. Xenon Pharmaceuticals (XENE) kompaniyasi uchun, uning nevrologiya sohasidagi kuchli ilmiy nufuzini hisobga olgan holda, GURU.Markets platformasida uzoq muddatli qarzning kapitalga nisbatini tahlil qilish innovatsion investitsiyalar va qarz yuklamasi o'rtasidagi muvozanatni baholash imkonini beradi hamda kompaniyaning fundamental ishonchliligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|VKTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Denali Corp (DNLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BHVN (biohavenpharma.com)|Uzoq muddatli qarzning kapitalga nisbati AMLX|TRVI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines PRAX|AVXL: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CBLL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Prothena Corporation PLC|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ANNX|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|NGNE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AC Immune (ACIU)|VYGR: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NMRA (Neumora Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti SCLX|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|ACOG - Uzoq muddatli qarzning kapitalga nisbati|Cognition Therapeutics (CGTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|inhibikase.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Therapeutics (ASRT)|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alterity Therapeutics|CLNN (clene.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|RLMD (relmada.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|RVPH - Uzoq muddatli qarzning kapitalga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|minervaneurosciences.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Addex Therapeutics Ltd. (ADXN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati